Epigenetic Markers May be Used to Estimate Anal Cancer Risk

News   May 31, 2017 | Original story from Queen Mary University London

 
Epigenetic Markers May be Used to Estimate Anal Cancer Risk

Microscope image of abnormal cells within the anus. Credit: QMUL

 
 
 

RELATED ARTICLES

MicroRNA Helps Cancer Evade Immune System

News

Salk researchers discover how oxygen-deprived tumors survive body’s immune response.

READ MORE

Cancer-fighting Cells Get a Boost from Oxygen Starvation Treatment

News

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training – that is, learning to perform well under low-oxygen conditions.

READ MORE

CRISPR Reveals the Sugary Secrets of the Cancer-related Notch Protein

News

New research shows that the fucose and glucose modifications serve as quality-control markers that allow Notch to be transported to its final destination in the cell membrane.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE